pantothenic acid has been researched along with valproic acid in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Hauhart, RE; Thurston, JH | 2 |
| Fukuyama, Y; Izumi, T; Osawa, M; Utsumi, H | 1 |
| Kharlamov, AN; Rayevsky, KS | 1 |
| Kharlamov, AN; Raevskiĭ, KS | 1 |
| Nagao, T; Sato, M; Shirota, M | 1 |
| Baggot, PJ; Kalamarides, JA; Shoemaker, JD | 1 |
| Dawson, JE; Raymond, AM; Winn, LM | 1 |
| Felker, D; Johnson, DE; Lynn, A; Wang, S | 1 |
1 review(s) available for pantothenic acid and valproic acid
| Article | Year |
|---|---|
Evidence for a potential protective effect of carnitine-pantothenic acid co-treatment on valproic acid-induced hepatotoxicity.
Topics: Animals; Anticonvulsants; Bipolar Disorder; Carnitine; Chemical and Drug Induced Liver Injury; Child; Drug Therapy, Combination; Humans; Oxidative Stress; Pantothenic Acid; Seizures; Valproic Acid | 2014 |
10 other study(ies) available for pantothenic acid and valproic acid
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Amelioration of adverse effects of valproic acid on ketogenesis and liver coenzyme A metabolism by cotreatment with pantothenate and carnitine in developing mice: possible clinical significance.
Topics: Animals; Animals, Suckling; Carnitine; Coenzyme A; Cysteine; Ketone Bodies; Liver; Mice; Pantothenic Acid; Valproic Acid | 1992 |
[A clinico-biochemical study of acute encephalopathy in patients treated with Ca-hopantenate].
Topics: Acute Disease; Adolescent; Adult; Age Factors; Blood Chemical Analysis; Brain Diseases; Child; Child, Preschool; Female; gamma-Aminobutyric Acid; Humans; Infant; Male; Pantothenic Acid; Reye Syndrome; Valproic Acid | 1985 |
GABA-ergic drugs: effects on conditioning, memory and learning.
Topics: Aminooxyacetic Acid; Animals; Conditioning, Operant; gamma-Aminobutyric Acid; Learning; Male; Memory; Motor Activity; Pantothenic Acid; Piracetam; Rats; Rats, Inbred Strains; Valproic Acid | 1983 |
[Tranquilizing effect of n-dipropylacetate and other GABA-ergic substances in conflict situations].
Topics: Acetates; Aminooxyacetic Acid; Animals; Bicuculline; Caffeine; Conflict, Psychological; Male; Models, Psychological; Pantothenic Acid; Pentylenetetrazole; Piracetam; Pyrrolidinones; Rats; Tranquilizing Agents; Valproic Acid | 1980 |
Vitamins to prevent neural-tube defects.
Topics: Epilepsy; Female; Humans; Neural Tube Defects; Pantothenic Acid; Pregnancy; Pregnancy Complications; Valproic Acid; Vitamins | 1993 |
Pantothenic acid decreases valproic acid-induced neural tube defects in mice (I).
Topics: Abnormalities, Drug-Induced; Animals; Anticonvulsants; Bone and Bones; Embryo, Mammalian; Eyelids; Female; Male; Mice; Mice, Inbred ICR; Neural Tube Defects; Pantothenic Acid; Pregnancy; Valproic Acid | 1995 |
Valproate-induced biochemical abnormalities in pregnancy corrected by vitamins: a case report.
Topics: Adult; Anticonvulsants; Epilepsy; Ethosuximide; Female; Humans; Metabolic Diseases; Pantothenic Acid; Pregnancy; Pregnancy Complications; Valproic Acid; Vitamins | 1999 |
Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice.
Topics: Animals; Anticonvulsants; bcl-2-Associated X Protein; Dose-Response Relationship, Drug; Female; Fetal Diseases; Folic Acid; Gestational Age; Immunoblotting; Injections, Subcutaneous; Male; Mice; Neural Tube Defects; NF-kappa B; Pantothenic Acid; Pregnancy; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myb; Proto-Oncogene Proteins c-pim-1; Tumor Suppressor Protein p53; Valproic Acid; Vitamin B Complex | 2006 |